{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-011148","form_type":"8-K","ticker":"CYCN","cik":"0001755237","company_name":"Cyclerion Therapeutics, Inc.","filed_at":"2022-06-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.176172+00:00","generated_at":"2026-06-25T04:49:47.808634+00:00","sec_items":["3.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Cyclerion receives Nasdaq deficiency notice for bid price below $1; 180-day cure period to Nov 28, 2022","bullets":["Received Nasdaq deficiency letter on June 1, 2022, for failing minimum $1 bid price for 30 consecutive business days.","Has until November 28, 2022, to regain compliance with bid price closing at $1 for 10 consecutive days.","May transfer to Nasdaq Capital Market or effect a reverse stock split if needed to cure the deficiency.","No assurance of regaining compliance; failure could lead to delisting and appeal process."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-011148","json":"https://secwatch.observer/filing/0000950170-22-011148.json","markdown":"https://secwatch.observer/filing/0000950170-22-011148.md","text":"https://secwatch.observer/filing/0000950170-22-011148.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1755237/000095017022011148/0000950170-22-011148-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1755237/000095017022011148/cycn-20220603.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T04:49:47.808634+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}